Author:
Slavin M A,Grigg A P,Schwarer A P,Szer J,Spencer A,Sainani A,Thursky K A,Roberts A W
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference20 articles.
1. Petersen F, Thornquist M, Buckner C, Counts G, Nelson N, Meyers J et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 1988; 16: 199–208.
2. Roberts AW, Grigg AP, de Boer R, Panuncialman G, Brown G, Street A et al. A pilot study of prophylactic intravenous antibodies to prevent fever and infection during allogeneic bone marrow transplantation. ANZ J Med 1993; 23: 141.
3. Avril M, Hartmann O, Valteau-Couanet D, Brugieres L, Kalifa C, Lemerle J . Antiinfective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation. Pediatr Hematol Oncol 1994; 11: 63–73.
4. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–751.
5. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18: 3038–3051.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献